As of 12:59pm ET
| +0.165 / +2.54%|
The 6 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 12.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +80.32% increase from the last price of 6.66.
The current consensus among 7 polled investment analysts is to Hold stock in Raptor Pharmaceutical Corp. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.